These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9826718)

  • 1. The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein.
    Puri A; Hug P; Jernigan K; Barchi J; Kim HY; Hamilton J; Wiels J; Murray GJ; Brady RO; Blumenthal R
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14435-40. PubMed ID: 9826718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of glycosphingolipids in HIV-1 entry: requirement of globotriosylceramide (Gb3) in CD4/CXCR4-dependent fusion.
    Puri A; Hug P; Jernigan K; Rose P; Blumenthal R
    Biosci Rep; 1999 Aug; 19(4):317-25. PubMed ID: 10589997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.
    Hug P; Lin HM; Korte T; Xiao X; Dimitrov DS; Wang JM; Puri A; Blumenthal R
    J Virol; 2000 Jul; 74(14):6377-85. PubMed ID: 10864648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion.
    Fantini J; Hammache D; Piéroni G; Yahi N
    Glycoconj J; 2000; 17(3 -4):199-204. PubMed ID: 11201791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.
    Rawat SS; Eaton J; Gallo SA; Martin TD; Ablan S; Ratnayake S; Viard M; KewalRamani VN; Wang JM; Blumenthal R; Puri A
    Virology; 2004 Jan; 318(1):55-65. PubMed ID: 14972535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.
    Berson JF; Long D; Doranz BJ; Rucker J; Jirik FR; Doms RW
    J Virol; 1996 Sep; 70(9):6288-95. PubMed ID: 8709256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human erythrocyte glycosphingolipids as alternative cofactors for human immunodeficiency virus type 1 (HIV-1) entry: evidence for CD4-induced interactions between HIV-1 gp120 and reconstituted membrane microdomains of glycosphingolipids (Gb3 and GM3).
    Hammache D; Yahi N; Maresca M; Piéroni G; Fantini J
    J Virol; 1999 Jun; 73(6):5244-8. PubMed ID: 10233996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins.
    Dragic T; Picard L; Alizon M
    J Virol; 1995 Feb; 69(2):1013-8. PubMed ID: 7815477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1-induced perturbations of glycosphingolipid metabolism are cell-specific and can be detected at early stages of HIV-1 infection.
    Fantini J; Tamalet C; Hammache D; Tourrès C; Duclos N; Yahi N
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):221-9. PubMed ID: 9803963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope.
    Castedo M; Roumier T; Blanco J; Ferri KF; Barretina J; Tintignac LA; Andreau K; Perfettini JL; Amendola A; Nardacci R; Leduc P; Ingber DE; Druillennec S; Roques B; Leibovitch SA; Vilella-Bach M; Chen J; Este JA; Modjtahedi N; Piacentini M; Kroemer G
    EMBO J; 2002 Aug; 21(15):4070-80. PubMed ID: 12145207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human erythrocyte glycolipids promote HIV-1 envelope glycoprotein-mediated fusion of CD4+ cells.
    Puri A; Hug P; Muñoz-Barroso I; Blumenthal R
    Biochem Biophys Res Commun; 1998 Jan; 242(1):219-25. PubMed ID: 9439639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4.
    Ye Z; Harmison GG; Ragheb JA; Schubert M
    Retrovirology; 2005 Dec; 2():80. PubMed ID: 16371160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric quantification of plasma glycosphingolipids in human GM3 ganglioside deficiency.
    Aoki K; Heaps AD; Strauss KA; Tiemeyer M
    Clin Mass Spectrom; 2019 Nov; 14 Pt B():106-114. PubMed ID: 34917767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
    Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
    Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein.
    Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells.
    Puri A; Rawat SS; Lin HM; Finnegan CM; Mikovits J; Ruscetti FW; Blumenthal R
    AIDS; 2004 Apr; 18(6):849-58. PubMed ID: 15060432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varying effects of temperature, Ca(2+) and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins.
    Jernigan KM; Blumenthal R; Puri A
    FEBS Lett; 2000 Jun; 474(2-3):246-51. PubMed ID: 10838094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD26 antigen and HIV fusion?
    Broder CC; Nussbaum O; Gutheil WG; Bachovchin WW; Berger EA
    Science; 1994 May; 264(5162):1156-9; author reply 1162-5. PubMed ID: 7909959
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of HIV env gene in a human T cell line for a rapid and quantifiable cell fusion assay.
    Moir S; Poulin L
    AIDS Res Hum Retroviruses; 1996 Jun; 12(9):811-20. PubMed ID: 8738433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD26 antigen and HIV fusion?
    Camerini D; Planelles V; Chen IS
    Science; 1994 May; 264(5162):1160-1; author reply 1162-5. PubMed ID: 7909961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.